method of quantifying u043fu043eu043bu0438u0433u0435u043au0441u0430u043cu0435u0442u0438u043bu0435u043du0431u0438u0430u0433u0443u0430u043du0438u0434u0438u043du0430 (u043fu0433u043cu0431) u0433u0438u0434u0440u043eu0445u043bu043eu0440u0438u0434u0430 in formulations for the preparation of liquid medicines for the treatment of u0437u0430u0431u043e u043bu0435u0432u0430u043du0438u0439 eyes and nose and the drug vehicle for the treatment of diseases of the eye (2 versions), compositions for the preparation of liquid medicines for the treatment of u0437u0430u0431u043eu043b u0435u0432u0430u043du0438u0439 eyes and nose containing u043fu0433u043cu0431 hydrochloride (28 variants)and medication for the treatment of diseases of the eye, which u043fu0433u043cu0431 hydrochloride

摘要

the invention belongs to the field of pharmacy, in particular to the pharmaceutical chemistry and technology of preparation of medicines.there are the following facilities: ways of quantifying u043fu043eu043bu0438u0433u0435u043au0441u0430u043cu0435u0442u0438u043bu0435u043du0431u0438u0433u0443u0430u043du0438u0434u0438u043du0430 (u043fu0433u043cu0431) u0433u0438u0434u0440u043eu0445u043bu043eu0440u0438u0434u0430 (2 versions), compositions for preparing liquid l u0435u043au0430u0440u0441u0442u0432u0435u043du043du044bu0445 means for treatment of diseases of the eye and the nose, with u043fu0433u043cu0431 hydrochloride (28 options), and medication for the treatment of diseases of the eye, u0441u043eu0434u0435u0440u0436 u0430u0449u0435u0435 u043fu0433u043cu0431 hydrochloride.methods of quantifying u043fu043eu043bu0438u0433u0435u043au0441u0430u043cu0435u0442u0438u043bu0435u043du0431u0438u0433u0443u0430u043du0438u0434u0438u043du0430 (u043fu0433u043cu0431) u0433u0438u0434u0440u043eu0445u043bu043eu0440u0438u0434u0430 based on optical density measurement of the optical density of the solutions with the subsequent mathematical calculation.compositions for the preparation of liquid medicines for the treatment of diseases of eyes and nose, containing u043fu043eu043bu0438u0433u0435u043au0441u0430u043cu0435u0442u0438u043bu0435u043du0431u0438u0433u0443u0430u043du0438u0434u0438u043du0430 (u043fu0433u043cu0431) hydrochloride have bottom do toxicity and not lose their properties over a long period (over two years). this is achieved through the use of a new type preservative - u043fu043eu043bu0438u0433u0435u043au0441u0430u043cu0435u0442u0438u043bu0435u043du0431u0438u0433u0443u0430u043du0438u0434u0438u043du0430 (u043fu0433u043cu0431) u0433u0438u0434u0440u043eu0445u043bu043eu0440u0438u0434u0430.medication for treating diseases of the eye, which u043fu043eu043bu0438u0433u0435u043au0441u0430u043cu0435u0442u0438u043bu0435u043du0431u0438u0433u0443u0430u043du0438u0434u0438u043du0430 (u043fu0433u043cu0431) hydrochloride, expands the arsenal in this oh u0431u043bu0430u0441u0442u0438.